Publications

Export 812 results:
Sort by: [ Author  (Desc)] Title Type Year
A B [C] D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
C
Crews, D. C., A. K. Bello, and G. Saadi, "Burden, access, and disparities in kidney disease.", Kidney international, vol. 95, issue 2, pp. 242-248, 2019.
Creswell, J. W., Research {Design}: {Qualitative} {Approaches}, , Thousand Oaks, California, Sage, 1994. Abstract
n/a
Crestini, C., N. M. N. El Hadidi, and G. Palleschi, "Characterisation of archaeological wood: A case study on the deterioration of a coffin", Microchemical Journal, vol. 92, issue 2, pp. 150-154, 2009. deterioration_of_a_coffin.pdf
Cravener, T. L., W. B. Roush, and M. M. Mashaly, "Broiler production under varying population densities", Poultry science, vol. 71, issue 3: Poultry Science Association, pp. 427-433, 1992. Abstract
n/a
Crapulli, F., M. Elhalwagy, R. Boiocchi, G. Raspa, and D. Santoro, "Linking upstream bioprocesses to ultraviolet disinfection using copula, artificial neural networks and Benchmark simulation model n.2", 10th International Water Association (IWA) Symposium on Modelling and Integrated Assessment, Copenhagen, Denmark, 1-4 September, 2019.
Crandall, S. H., and A. El-Shafei, "Momentum and energy approximations for elementary squeeze-film damper flows", Journal of applied mechanics, vol. 60, pp. 728, 1993. Abstract
n/a
Cozma, C., M. Hovakimyan, M. - I. Iurașcu, I. G. Mahmoud, N. A. M. Menabawy, P. Bauer, and A. Rolfs, "Genetic, clinical and biochemical characterization of a large cohort of patients with hyaline fibromatosis syndrome", Orphanet journal of rare Disease, vol. 14, issue 1, pp. 1-10, 2019.
Coyne, S., A. Litomska, C. Chizzali, M. N. A. Khalil, K. Richter, L. Beerhues, and C. Hertweck, "Control of Plant Defense Mechanisms and Fire Blight Pathogenesis through the Regulation of 6-Thioguanine Biosynthesis in Erwinia amylovora", ChemBioChem, vol. 15, no. 3: Wiley Online Library, pp. 373–376, 2014. Abstract
n/a
Coyne, S., C. Chizzali, M. N. A. Khalil, A. Litomska, K. Richter, L. Beerhues, and C. Hertweck, "Biosynthesis of the Antimetabolite 6-Thioguanine in Erwinia amylovora Plays a Key Role in Fire Blight Pathogenesis", Angewandte Chemie, vol. 125, no. 40: Wiley Online Library, pp. 10758–10762, 2013. Abstract
n/a
Coyne, S., C. Chizzali, M. N. A. Khalil, A. Litomska, K. Richter, L. Beerhues, and C. Hertweck, "Titelbild: Biosynthesis of the Antimetabolite 6-Thioguanine in Erwinia amylovora Plays a Key Role in Fire Blight Pathogenesis (Angew. Chem. 40/2013)", Angewandte Chemie, vol. 125, no. 40: Wiley Online Library, pp. 10583–10583, 2013. Abstract
n/a
Coyne, S., A. Litomska, C. Chizzali, M. N. A. Khalil, K. Richter, L. Beerhues, and C. Hertweck, Control of plant defense mechanisms and fire blight pathogenesis through the regulation of 6‐thioguanine biosynthesis in Erwinia amylovora, , vol. 15, issue 3: WILEY‐VCH Verlag Weinheim, pp. 373 - 376, 2014. Abstract
n/a
Coyne, S., C. Chizzali, M. N. A. Khalil, A. Litomska, K. Richter, L. Beerhues, and C. Hertweck, "Cover Picture: Biosynthesis of the Antimetabolite 6-Thioguanine in Erwinia amylovora Plays a Key Role in Fire Blight Pathogenesis (Angew. Chem. Int. Ed. 40/2013)", Angewandte Chemie International Edition, vol. 52, no. 40: Wiley Online Library, pp. 10391–10391, 2013. Abstract
n/a
Coyne, S., C. Chizzali, M. N. A. Khalil, A. Litomska, K. Richter, L. Beerhues, and C. Hertweck, Biosynthesis of the antimetabolite 6‐thioguanine in Erwinia amylovora plays a key role in fire blight pathogenesis, , vol. 125, issue 40: WILEY‐VCH Verlag Weinheim, pp. 10758 - 10762, 2013. Abstract
n/a
Cox, B., and S. Ghoneim, "Strategic Use of EDI in the Public Sector: The HMSO Case Study", Journal of Strategic Information Systems, vol. 7, issue 1, pp. 37-51, 1998.
Cox, J. V., Y. M. AbdelRahman, J. Peters, N. Naher, and R. J. Belland, "Chlamydia trachomatis utilizes the mammalian CLA1 lipid transporter to acquire host phosphatidylcholine essential for growth.", Cellular microbiology, vol. 18, issue 3, pp. 305-18, 2016 Mar. Abstractcox_et_al-2016-cellular_microbiology.pdf

Phosphatidylcholine is a constituent of Chlamydia trachomatis membranes that must be acquired from its mammalian host to support bacterial proliferation. The CLA1 (SR-B1) receptor is a bi-directional phosphatidylcholine/cholesterol transporter that is recruited to the inclusion of Chlamydia-infected cells along with ABCA1. C. trachomatis growth was inhibited in a dose-dependent manner by BLT-1, a selective inhibitor of CLA1 function. Expression of a BLT-1-insensitive CLA1(C384S) mutant ameliorated the effect of the drug on chlamydial growth. CLA1 knockdown using shRNAs corroborated an important role for CLA1 in the growth of C. trachomatis. Trafficking of a fluorescent phosphatidylcholine analogue to Chlamydia was blocked by the inhibition of CLA1 or ABCA1 function, indicating a critical role for these transporters in phosphatidylcholine acquisition by this organism. Our analyses using a dual-labelled fluorescent phosphatidylcholine analogue and mass spectrometry showed that the phosphatidylcholine associated with isolated Chlamydia was unmodified host phosphatidylcholine. These results indicate that C. trachomatis co-opts host phospholipid transporters normally used to assemble lipoproteins to acquire host phosphatidylcholine essential for growth.

Cox, B., and S. Ghoneim, "Extending the Role of EDI: The HMSO Case Study", 4th European Conference of Information Systems, July 1996, Portugal, 1996.
Cox, T. M., G. Drelichman, R. Cravo, M. Balwani, T. A. Burrow, A. M. Martins, E. Lukina, B. Rosenbloom, O. Goker-Alpan, N. Watman, et al., "Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy.", Blood, vol. 129, issue 17, pp. 2375-2383, 2017 04 27. Abstract

In the phase 3 Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE), at 1 year, eliglustat was noninferior to imiglucerase enzyme therapy in maintaining stable platelet counts, hemoglobin concentrations, and spleen and liver volumes. After this primary analysis period, patients entered a long-term extension phase in which all received eliglustat. Duration on eliglustat ranged from 2 to 5 years, depending on timing of enrollment (which spanned 2 years), treatment group to which patients were randomized, and whether they lived in the United States when commercial eliglustat became available. Here we report long-term safety and efficacy of eliglustat for 157 patients who received eliglustat in the ENCORE trial; data are available for 46 patients who received eliglustat for 4 years. Mean hemoglobin concentration, platelet count, and spleen and liver volumes remained stable for up to 4 years. Year to year, all 4 measures remained collectively stable (composite end point relative to baseline values) in ≥85% of patients as well as individually in ≥92%. Mean bone mineral density z scores (lumbar spine and femur) remained stable and were maintained in the healthy reference range throughout. Eliglustat was well tolerated over 4 years; 4 (2.5%) patients withdrew because of adverse events that were considered related to the study drug. No new or long-term safety concerns were identified. Clinical stability assessed by composite and individual measures was maintained in adults with Gaucher disease type 1 treated with eliglustat who remained in the ENCORE trial for up to 4 years. This trial was registered at www.clinicaltrials.gov as #NCT00943111.

Cox, B., and S. Ghoneim, "Drivers and Barriers to Adopting EDI: A Sector Analysis of UK Industry", European Journal of Information Systems, vol. 5, issue 1, pp. 24-33, 1996.
Cox, B., and S. Ghoneim, "EDI, Trade Facilitation and Customs Reform”", Trade Policy Developments in the MENA, Washington, The World Bank, 2000.
Cox, B., and S. Ghoneim, "Developing a National EDI Strategy", Business Information Technology Management: Closing the International Divide: Har-Anand Publications PVT LTd, 1997.
Cox, B., and S. Ghoneim, "Benefits and Barriers to Adopting EDI in the UK - A Sector Survey", Second Conference on Information Systems, 30-31 May, 1994, Nijenrode University, The Netherlands Business School, Netherlands, Nijenrode University, The Netherlands Business School, Netherlands, Nijenrode University, The Netherlands Business School, Netherlands, 1994.
Cox, B., and S. Ghoneim, "EDI, Theoretical Framework and Lessons from Experience", Egyptian Exports and Challenges in the 21st Century, Cairo, Center for Economics and Financial Research Studies, Cairo University, 2000.
Cox, J. V., N. Naher, Y. M. AbdelRahman, and R. J. Belland, "Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth", Cellular Microbiology, vol. 14, no. 10: Wiley Online Library, pp. 1497–1512, 2012. Abstract
n/a
Cox, B., and S. Ghoneim, "Electronic Data Interchange (EDI) and Trade Facilitation: Best Practice and Lessons from Experience", 2nd Mediterranean Development Forum, Marrakech, Morocco, 1998.
Cox, B., and S. Ghoneim, "Implementing a National EDI Service: Issues in Developing Countries & Lessons from the U.K.", Annual International Federation for Information Processing (IFIP) WG 9.4 1995 Conference on Information and Technology and Socio-Economic Development Challenges and Opportunities, Cairo Egypt, 1995.
Tourism